These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1481155)

  • 1. [Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
    Mazur NA; Vasil'eva NN; Pavlova TS; Kul'ginskaia IV; Zhdanova SM
    Ter Arkh; 1992; 64(9):50-3. PubMed ID: 1481155
    [No Abstract]   [Full Text] [Related]  

  • 2. [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Mazur NA; Pavlova TS; Vasil'eva NN; Kul'ginskaia IV
    Ter Arkh; 1994; 66(8):26-30. PubMed ID: 7527161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-channel blockers and gingival hyperplasia.
    Tam IM; Wandres DL
    Ann Pharmacother; 1992 Feb; 26(2):213-4. PubMed ID: 1554935
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
    Gillis AM; Clusin WT
    Compr Ther; 1984 Sep; 10(9):60-7. PubMed ID: 6207977
    [No Abstract]   [Full Text] [Related]  

  • 7. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of calcium antagonists on long-term prognosis of patients with myocardial infarction].
    Novikova NA
    Kardiologiia; 2002; 42(3):62-3. PubMed ID: 12494189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
    Iskenderov BG; Burmistrova LF; Berenshteĭn NV; Lokhina TV
    Kardiologiia; 2007; 47(11):44-5. PubMed ID: 18260963
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circadian rhythms in coronary heart disease. Their pathophysiology and significance for myocardial ischemia, acute myocardial infarct and sudden cardiac death].
    Zehender M; Hohnloser S; Just H
    Dtsch Med Wochenschr; 1992 Apr; 117(16):629-37. PubMed ID: 1568431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Dotzer F; Gromer H
    Fortschr Med; 1993 May; 111(14):245-8. PubMed ID: 8335304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counting heart beats: a peephole into prediction of sudden and nonsudden cardiac death.
    La Rovere MT; Schwartz PJ
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):174-5. PubMed ID: 12693500
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil and circadian variation of sudden cardiac death.
    Andersen L; Sigurd B; Hansen J
    Am Heart J; 1996 Feb; 131(2):409-10. PubMed ID: 8579045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term treatment with calcium antagonists: advantageous effects and risks].
    van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing angina with calcium channel blockers.
    Segal BL; Kotler MN; Iskandrian AS
    Geriatrics; 1982 Nov; 37(11):65-70. PubMed ID: 6127283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.